Molnupiravir, also known by its brand name MK-4488, represents a important advancement in the battle against the pandemic. This oral antiviral compound works by introducing errors into the SARS-CoV-2's genetic sequence, effectively halting its replication and transmission within the individual. While first data indicated a significant reduction in